Russell Frank Company’s ANI Pharmaceuticals ANIP Stock Holding History

Russell Frank Company’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$38K	Sell	1,129 -27,046	-96%	-$917K	﹤0.01%	2897
2015 Q4	$1.32M	Sell	28,175 -33,770	-55%	-$1.45M	﹤0.01%	2073
2015 Q3	$2.45M	Buy	61,945 +5,669	+10%	+$323K	﹤0.01%	1725
2015 Q2	$3.49M	Buy	56,276 +10,206	+22%	+$607K	0.01%	1653
2015 Q1	$2.88M	Sell	46,070 -28,851	-39%	-$1.75M	0.01%	1560
2014 Q4	$4.22M	Buy	74,921 +22,469	+43%	+$991K	0.01%	1392
2014 Q3	$1.48M	Sell	52,452 -8,706	-14%	-$261K	﹤0.01%	1878
2014 Q2	$1.67M	Buy	61,158 +479	+0.8%	+$15K	﹤0.01%	1842
2014 Q1	$1.9M	Buy	+60,679	New	+$1.61M	﹤0.01%	1794
2013 Q4	–	Sell	-424	Closed	-$4K	–	2799
2013 Q3	$4K	Sell	424 -1	-0.2%	-$7	﹤0.01%	3326
2013 Q2	$3K	Buy	+425	New	+$2.97K	﹤0.01%	3143

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Russell Frank Company's ANIP Position: Q1 2016 in Review

Russell Frank Company reduced its ANI Pharmaceuticals (ANIP) stake by 96% in Q1 2016, selling an estimated $917K and leaving 1,129 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

Russell Frank Company first reported a position in ANIP in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.22M in Q4 2014. 121 funds tracked by Wall St. Rank hold ANIP as of Q1 2016.

Russell Frank Company held 1,129 shares of ANI Pharmaceuticals worth $38K as of Q1 2016.
Russell Frank Company sold 27,046 ANI Pharmaceuticals shares in Q1 2016, an estimated $917K.
ANI Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2897 holding.
Russell Frank Company first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 11 quarters since.
Russell Frank Company's ANI Pharmaceuticals position peaked at $4.22M in Q4 2014.
121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.